Arcturus Therapeutics Files 8-K on Financials

Ticker: ARCT · Form: 8-K · Filed: Mar 6, 2025 · CIK: 1768224

Arcturus Therapeutics Holdings Inc. 8-K Filing Summary
FieldDetail
CompanyArcturus Therapeutics Holdings Inc. (ARCT)
Form Type8-K
Filed DateMar 6, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-condition, results-of-operations, filing

Related Tickers: ARCT

TL;DR

ARCT filed an 8-K detailing financial condition and results of operations.

AI Summary

Arcturus Therapeutics Holdings Inc. filed an 8-K on March 6, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located at 10628 Science Center Drive, Suite 250, San Diego, California.

Why It Matters

This filing provides crucial updates on Arcturus Therapeutics' financial health and operational results, which are important for investors to assess the company's performance and future prospects.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of financial information and does not contain any new material events or risks.

Key Players & Entities

  • Arcturus Therapeutics Holdings Inc. (company) — Registrant
  • March 6, 2025 (date) — Date of earliest event reported
  • 10628 Science Center Drive, Suite 250, San Diego, California 92121 (address) — Principal executive offices
  • 001-38942 (company_id) — Commission File Number

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on Arcturus Therapeutics Holdings Inc.'s results of operations and financial condition, and to include financial statements and exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on March 6, 2025.

Where are Arcturus Therapeutics Holdings Inc.'s principal executive offices located?

Arcturus Therapeutics Holdings Inc.'s principal executive offices are located at 10628 Science Center Drive, Suite 250, San Diego, California 92121.

What is the Commission File Number for Arcturus Therapeutics Holdings Inc.?

The Commission File Number for Arcturus Therapeutics Holdings Inc. is 001-38942.

What is the Standard Industrial Classification code for Arcturus Therapeutics Holdings Inc.?

The Standard Industrial Classification code for Arcturus Therapeutics Holdings Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 6, 2025 regarding Arcturus Therapeutics Holdings Inc. (ARCT).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.